Recombinant Human Erythropoietin Treatment of Anemia in Renal Transplant Patients

References

• Winearls C G, Oliver D O, Pippard M J. Effect of human erythropoietin derived from recombinant DNA on anemia of patients maintained by chronic haemodialysis. Lancet 1986; 11: 1175–1178
   Google Scholar
• Eshbach J, Egrie J, Downing M, Browne J, Adamson J. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. results of a combined phase I and II clinical trial. N Engl J Med 1987; 316(8)73–78
   PubMedGoogle Scholar
• Lim V, DeGowin R, Zavala D, Kirchner P, Abels R, Perry P, Fangman J. Recombinant human erythropoietin treatment in predialysis patients. Ann Int Med 1989; 110(2)108–114
   PubMed Web of Science ®Google Scholar
• Yoshimura N, Oka T, Ohmori Y, Aikawa I. Effects of rHuEpo on the anemia of renal transplant recipients with chronic rejection—brief communication. Transplantation 1989; 48(3)527–529
   PubMed Web of Science ®Google Scholar
• Train D, Franz M, Cuningham S, Pohanka E, Watchinger B, Klaus R, Kovarik J. Recombinant human erythropoietin (rHuEpo) in patients with chronic renal transplant insufficiency and renal anemia. 27th Congress of the EDTA—ERA. Vienna 1990, Abstracts, 229
   Google Scholar
• Szurkowski M, Wiecek A, Kokot F, Daniel K. Safety and efficiency of recombinant human erythropoietin treatment in anemic pregnant women with a kidney transplant. Nephron 1994; 67: 242–243
   PubMed Web of Science ®Google Scholar
• Jindal K K, Hirsch D J, Belitsky P, Whalen M A. Low dose subcutaneous erythropoietin corrects the anemia of renal transplant failure. Nephrol Dial Transplant 1992; 7: 143–146
   PubMed Web of Science ®Google Scholar
• Eschbach J W, Cook J D, Scribner B H, Finich C A. Iron balance in hemodialysis patients. Ann Int Med 1977; 87: 710–713
   PubMed Web of Science ®Google Scholar
• Beguin Y, Clemons G, Oris R, Fillet G. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood 1991; 77(7)868–873
   PubMedGoogle Scholar
• Mitch W, Walser M, Buffington G, Leman J. A simple method of estimating progression of chronic renal failure. Lancet 1976; II: 1326–1328
   Google Scholar
• Wolf M, Jelkman W. Erythropoiesis and erythropoietin levels in renal transplant recipients. Klin Wochenschr 1991; 69: 53–58
   Google Scholar
• Spivak J. Recombinant erythropoietin. Annu Rev Med 1993; 44: 243–253
   PubMed Web of Science ®Google Scholar
• Chandra M, Clemons G, McVicar M. Relation of serum erythropoietin levels to renal excretory function: evidence for lowered set point for erythropoietin production in chronic renal failure. J Pediatr 1988; 113: 1015–1021
   PubMed Web of Science ®Google Scholar
• Eckardt K, Frei U, Kleim V, Bauer C, Koch M, Kurtz A. Role of excretory graft function for erythropoietin formation after renal transplantation. Eur J Clin Invest 1990; 20: 563–572
   PubMed Web of Science ®Google Scholar
• Howarth J E, Waters H M, Shanks D, Hyde K, Yin J A, Geary C G, Anastassiades E, Howart D, Gokac R. Effects of azathioprine on response of renal anemia to subcutaneous recombinant human erythropoietin. J Clin Pathol 1993; 46(1)41–44
   PubMed Web of Science ®Google Scholar
• Kuhn K, Nonnast-Daniel, Grutzmacher P, Gruner J, Pfaffl W, Baldamus C A, Scigalla P. Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Contrib Nephrol 1988; 66: 94–103
   PubMedGoogle Scholar
• Koury M J. Investigating erythropoietin resistance. N Engl J Med 1993; 328: 205–206
   PubMed Web of Science ®Google Scholar
• Almond M K, Tailor D, Marsh F P, Raftery M J, Cunningham J. Increased erythropoietin requirements in patients with failed renal transplants returning to a dialysis programme. Nephrol Dial Transplant 1994; 9: 270–273
   PubMed Web of Science ®Google Scholar
• Bommer J, Alexiou C, Muller-Buhl U, Eifert J, Ritz E. RHuEpo therapy in haemodialysis patients-dose determination and clinical experiance. Nephrol Dial Transplant 1987; 2: 238–242
   PubMedGoogle Scholar
• Sundal E, Kaeser U. Correction of anemia of chronic renal failure with recombinant human erythropoietin: safety and efficacy of one year's treatment in European multicentre study of 150 haemodialysis dependent patients. Nephrol Dial Transplant 1989; 4: 979–987
   PubMed Web of Science ®Google Scholar
• Koury M J, Bondurant M C. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid cells. Science 1990; 248: 378–381
   PubMed Web of Science ®Google Scholar
• Anastassiades E, Howarth J, Howart D, Shanks D, Waters H, Hyde K, Yin J L, Geary C, Gokal R. The influence of azathioprine on ferrokinetics of patients with renal failure before and after treatment with erythropoietin. XIIth International Congress of Nephrology, Jerusalem, 1994, 348, abstract
   Google Scholar
• Watson A. Iron management during treatment with recombinant human erythropoietin in chronic renal failure. J Clin Pharmac 1993; 33(12)1134–1138
   PubMed Web of Science ®Google Scholar
• Besarab A, Caro J, Jarrell B, Burke J, Fransos G, Mallon E, Karsch R. Effect of cyclosporine and delayed graft function on posttransplantation erythropoiesis. Transplantation 1985; 40: 624–631
   PubMed Web of Science ®Google Scholar
• Webb D B, Price K A, Hutton R D, Newcombe R G, Salaman J R, Orchard J. Polycythemia following renal transplantation: an association with azathioprine dosage. Am J Nephrol 1987; 7: 221–225
   PubMed Web of Science ®Google Scholar
• Anderson S. Effect of erythropoietin in predialysis patients. Am J Kidney Dis 1991; 17/5(suppl 1)103–106
   Google Scholar